Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
after those patents expired, and these could be manufactured by other companies as generics and sold to everyone for cheap, we really haven't discovered something like that since. So that's why the shift has really gone. And of course, we have new technology to do it too, but really shifted to biologics, the complex proteins that are, you know, harder to manufacture.
0
💬
0
Comments
Log in to comment.
There are no comments yet.